
SRNEQ
Healthcare · Biotechnology · $16.5M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2023
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 3, 2023 | Time not confirmed | -0.15 | 0.00 | +100.0% |
| Aug 14, 2023 | Before the open | -0.15 | -0.17 | -13.3% |
| May 15, 2023 | After the close | -0.16 | -0.26 | -62.5% |
| Mar 16, 2023 | Before the open | -0.19 | -0.46 | -142.1% |
| Nov 8, 2022 | After the close | -0.25 | -0.20 | +20.0% |
| Aug 15, 2022 | After the close | -0.25 | -0.54 | -116.0% |
| May 5, 2022 | After the close | -0.17 | -0.12 | +29.4% |
| Mar 11, 2022 | After the close | -0.29 | -0.47 | -62.1% |
| Nov 5, 2021 | After the close | -0.23 | -0.40 | -73.9% |
| Aug 6, 2021 | After the close | -0.20 | -0.57 | -185.0% |
| May 5, 2021 | After the close | 0.38 | 0.01 | -97.4% |
| Feb 19, 2021 | After the close | 2.72 | -0.27 | -109.9% |
| Nov 9, 2020 | After the close | -0.20 |
Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include…
| -0.33 |
| -65.0% |
| Aug 4, 2020 | After the close | -0.22 | -0.36 | -63.6% |
| May 11, 2020 | After the close | -0.20 | -0.23 | -15.0% |
| Mar 3, 2020 | After the close | -0.38 | -0.41 | -7.9% |
| Nov 12, 2019 | After the close | -0.43 | -0.50 | -16.3% |
| Aug 9, 2019 | After the close | -0.40 | -0.46 | -15.0% |
| May 15, 2019 | After the close | -0.34 | -0.88 | -158.8% |
| Mar 15, 2019 | Before the open | -0.27 | -0.41 | -51.9% |
| Nov 10, 2018 | Time not confirmed | -0.19 | -0.40 | -110.5% |
| Aug 10, 2018 | Before the open | -0.20 | -0.29 | -45.0% |
| May 10, 2018 | After the close | -0.16 | -0.38 | -137.5% |
| Mar 16, 2018 | After the close | -0.14 | 0.58 | +514.3% |